Dermata Therapeutics Inc (DRMA)
1.120
-0.07
(-5.79%)
USD |
NASDAQ |
Nov 15, 16:00
1.12
0.00 (0.00%)
After-Hours: 20:00
Dermata Therapeutics Total Assets (Quarterly): 5.237M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 5.237M |
| March 31, 2024 | 5.180M |
| December 31, 2023 | 7.979M |
| September 30, 2023 | 7.323M |
| June 30, 2023 | 8.713M |
| March 31, 2023 | 9.295M |
| December 31, 2022 | 6.944M |
| September 30, 2022 | 8.975M |
| Date | Value |
|---|---|
| June 30, 2022 | 11.03M |
| March 31, 2022 | 9.044M |
| December 31, 2021 | 11.62M |
| September 30, 2021 | 13.69M |
| June 30, 2021 | 1.137M |
| March 31, 2021 | 1.651M |
| December 31, 2020 | 0.6055M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.6055M
Minimum
Dec 2020
13.69M
Maximum
Sep 2021
7.228M
Average
7.979M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| NeuroBo Pharmaceuticals Inc | 22.15M |
| Cognition Therapeutics Inc | 34.37M |
| ZyVersa Therapeutics Inc | 19.47M |
| Bone Biologics Corp | 3.194M |
| NovaBay Pharmaceuticals Inc | 3.877M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.918M |
| Shareholders Equity (Quarterly) | 3.318M |